From: Regulation of nc886 (vtRNA2-1) RNAs is associated with cardiometabolic risk factors and diseases
YFS 2007; n = 1497; 30–45 y | DILGOM; n = 504; 25–74 y | LURIC; n = 2183; 17–92 y | KORA F4; n = 1653; 32–81 y | KORA FF4; n = 1771; 38–87 y | Bogalusa; n = 658; 36–57 y | NFBC1966; n = 792; 43–47 y | ||
---|---|---|---|---|---|---|---|---|
nc886 methylation | ||||||||
Imprinted | 73.20% | 72.20% | 72.00% | 76.50% | 75.10% | 71.60% | 71.80% | |
Intermethylated | 3.20% | 6.30% | 4.10% | 2.60% | 3.10% | 3.40% | 3.20% | |
Nonmethylated | 23.60% | 21.40% | 23.90% | 20.90% | 21.70% | 24.80% | 25.00% | |
Genotype | ||||||||
T/T | 81.60% | 85.40% | 85.10% | 86.80% | 86.50% | 85.40% | 83.10% | |
T/C | 17.40% | 14.00% | 14.50% | 12.70% | 12.70% | 14.00% | 16.10% | |
C/C | 1.00% | 0.40% | 0.40% | 0.50% | 0.70% | 0.40% | 0.80% | |
Proxy group | ||||||||
Imprinted T/T | 59.90% | 57.90% | 61.30% | 66.20% | 64.90% | 60.90% | 59.50% | 59,50% |
Intermethylated T/T | 2.80% | 5.90% | 3.60% | 2.20% | 2.60% | 2.70% | 2.80% | 2,80% |
Nonmethylated T/T | 18.90% | 18.40% | 20.20% | 18.40% | 19.00% | 21.80% | 20.80% | 20,80% |
Imprinted T/C | 12.60% | 13.70% | 10.40% | 9.90% | 9.70% | 10.30% | 12.00% | 12,00% |
Intermethylated T/C | 0.40% | 0.40% | 0.50% | 0.40% | 0.50% | 0.70% | 0.40% | 0,40% |
Nonmethylated T/C | 4.40% | 3.00% | 3.60% | 2.40% | 2.50% | 3.00% | 3.60% | 3,60% |
Imprinted C/C | 0.70% | 0.60% | 0.30% | 0.40% | 0.50% | 0.40% | 0.30% | 0,30% |
Intermethylated C/C | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Nonmethylated C/C | 0.30% | 0.00% | 0.10% | 0.10% | 0.20% | 0.00% | 0.60% | 0,60% |
Use in proxy | ||||||||
Control | 59.90% | 57.90% | 61.30% | 66.20% | 64.90% | 60.90% | 59.50% | |
Elevated nc886 RNA | 24.30% | 22.00% | 24.20% | 21.30% | 22.20% | 25.20% | 25.30% | |
Excluded | 15.80% | 20.00% | 14.50% | 12.50% | 12.80% | 13.70% | 15.20% |